923 results on '"Gustot, Thierry"'
Search Results
2. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
3. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts.
4. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
5. A machine learning-based classification of adult-onset diabetes identifies patients at risk of liver-related complications
6. EASL Clinical Practice Guidelines on acute-on-chronic liver failure
7. Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
8. THU-050 Urinary biomarkers of tubular and glomerular damage predict renal recovery in patients with hepatorenal syndrome-acute kidney injury
9. WED-098-YI Low-density lipoprotein can predict hospital readmissions and outcomes following acute decompensation of cirrhosis
10. THU-057-YI Distinguishing clinical profiles in acute-on-chronic liver failure: a comparative analysis of alcohol-related hepatitis versus infection precipitated acute-on-chronic liver failure
11. THU-335 The new nomenclature of steatosic liver disease identifies different risk trajectories for liver-related complications
12. THU-331-YI The humoral profile of immunoglobulins specific for microbiota antigens stratifies the severity of patients affected by alcohol-related liver disease and predicts their 90-d mortality
13. LBP-012 Epidemiological trends and clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis across Latin America: results from the ACLARA study
14. THU-092 Enrolling patients in ACLF trials-the need to increase ACLF awareness (DHELIVER trial)
15. LBP-026 The global prospective observational study to evaluate the role of ‘liver transplantation in patients with cirrhosis and severe acuteon-chronic liver failure (CHANCE)’: study design, demographics and overall outcome
16. LBO-004 Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
17. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
18. Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis
19. Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study
20. Erratum to “EASL Clinical Practice Guidelines on acute-on-chronic liver failure” [J Hepatol 79 (2023) 461–491]
21. Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital
22. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation
23. The use of automated pupillometry in critically ill cirrhotic patients with hepatic encephalopathy
24. Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital.
25. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
26. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
27. Acute-on-chronic liver failure in patients with alcohol-related liver disease
28. Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis
29. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
30. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
31. The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
32. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis
33. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts
34. Multidrug-Resistant Bacterial Infection in Patients with Cirrhosis. A Review
35. L’expérience des soins des personnes qui vivent une transplantation hépatique. Recherche phénoménologique descriptive au sein d’un hôpital académique belge
36. ACLF course profiles over screening period in the phase IIb DHELIVER study
37. A machine learning-based classification of adult-onset diabetes identifies patients at risk for liver-related complications
38. New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis
39. P-5 APACHE STUDY DESIGN TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA EXCHANGE WITH HUMAN SERUM ALBUMIN 5% ON SHORT-TERM SURVIVAL IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE AT HIGH RISK OF HOSPITAL MORTALITY.
40. Infection in Cirrhosis
41. Bacterial Infections in Patients with Cirrhosis
42. L’expérience des soins des personnes qui vivent une transplantation hépatique. Recherche phénoménologique descriptive au sein d’un hôpital académique belge
43. A machine learning-based classification of adult-onset diabetes identifies patients at risk for liver-related complications.
44. Deciphering the cellular and molecular mechanisms implicated in innate immune cell dysfunction in patients with alcohol- related cirrhosis
45. Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
46. Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease [Dataset]
47. Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis
48. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)
49. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
50. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.